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Identification of an Arsenic Resistance and Arsenic-Sensing System in
Campylobacter jejuni
Abstract
Arsenic is commonly present in the natural environment and is also used as a feed additive for animal
production. Poultry is a major reservoir for Campylobacter jejuni, a major food-borne human pathogen causing
gastroenteritis. It has been shown that Campylobacter isolates from poultry are highly resistant to arsenic
compounds, but the molecular mechanisms responsible for the resistance have not been determined, and it is
unclear if the acquired arsenic resistance affects the susceptibility of Campylobacter spp. to other
antimicrobials. In this study, we identified a four-gene operon that contributes to arsenic resistance in
Campylobacter. This operon encodes a putative membrane permease (ArsP), a transcriptional repressor
(ArsR), an arsenate reductase (ArsC), and an efflux protein (Acr3). PCR analysis of various clinical C. jejuni
isolates indicated a significant association of this operon with elevated resistance to arsenite and arsenate.
Gene-specific mutagenesis confirmed the role of the ars operon in conferring arsenic resistance. It was further
shown that this operon is subject to regulation by ArsR, which directly binds to the ars promoter and inhibits
the transcription of the operon. Arsenite inhibits the binding of ArsR to the ars promoter DNA and induces
the expression of the ars genes. Mutation of the ars genes did not affect the susceptibility of C. jejuni to
commonly used antibiotics. These results identify the ars operon as an important mechanism for arsenic
resistance and sensing in Campylobacter.
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Arsenic is commonly present in the natural environment and is also used as a feed additive for animal
production. Poultry is a major reservoir for Campylobacter jejuni, a major food-borne human pathogen
causing gastroenteritis. It has been shown that Campylobacter isolates from poultry are highly resistant to
arsenic compounds, but the molecular mechanisms responsible for the resistance have not been deter-
mined, and it is unclear if the acquired arsenic resistance affects the susceptibility of Campylobacter spp.
to other antimicrobials. In this study, we identified a four-gene operon that contributes to arsenic
resistance in Campylobacter. This operon encodes a putative membrane permease (ArsP), a transcriptional
repressor (ArsR), an arsenate reductase (ArsC), and an efflux protein (Acr3). PCR analysis of various
clinical C. jejuni isolates indicated a significant association of this operon with elevated resistance to
arsenite and arsenate. Gene-specific mutagenesis confirmed the role of the ars operon in conferring
arsenic resistance. It was further shown that this operon is subject to regulation by ArsR, which directly
binds to the ars promoter and inhibits the transcription of the operon. Arsenite inhibits the binding of
ArsR to the ars promoter DNA and induces the expression of the ars genes. Mutation of the ars genes did
not affect the susceptibility of C. jejuni to commonly used antibiotics. These results identify the ars operon
as an important mechanism for arsenic resistance and sensing in Campylobacter.
Arsenic is a toxic metalloid present in the natural environ-
ment. At high levels, arsenic is toxic to most cells, including
microbial organisms (32, 33). To survive this toxicity, bacterial
organisms have evolved multiple mechanisms for arsenic de-
toxification, including extrusion mediated by efflux transport-
ers, reduction of arsenate [As(V)] to arsenite [As(III)], which
is subsequently extruded by efflux transporters, and methyl-
ation of As(III) by S-adenosylmethionine methyltransferase
(39, 41). These resistance mechanisms are encoded by various
ars genes, and the best-characterized ones include arsR, arsA,
arsB, arsC, arsD, arsH, and arsM. The arsR gene encodes
an As(III)-responsive transcriptional repressor, which controls
the expression of other ars genes by binding to target promot-
ers (42, 55). ArsA and ArsB form an oxyanion-translocating
complex, in which ArsA functions as an ATPase, while ArsB
is a membrane efflux transporter (41). In addition, ArsB can
function alone (without ArsA) in the extrusion of arsenite
(9). arsC encodes a arsenate reductase, which converts ar-
senate to arsenite (20). ArsD was previously thought to be
an inducer-independent regulatory protein, but recent work
indicated that it functions as an arsenic metallochaperone
transferring As(III) to ArsA and increasing the rate of ar-
senic extrusion (26, 27, 57). arsH encodes an NADPH-flavin
mononucleotide oxidoreductase and has been shown to be
involved in arsenic resistance in Yersinia enterocolitica and
Sinorhizobium meliloti (31, 59, 60). The newly identified
arsenic resistance gene arsM encodes an arsenite S-adeno-
sylmethionine methyltransferase that methylates arsenite to
volatile trimethylarsine, contributing to arsenic detoxifica-
tion in bacteria (39). In bacteria, the ars genes can be carried
on either plasmids or chromosomes and are often organized
in operons, such as arsRBC, arsRABC, and arsRDABC, but
in some cases the ars genes exist singly (3–5, 10, 29, 45, 50).
Campylobacter jejuni is a leading cause of bacterial gastro-
enteritis in humans and is estimated to be responsible for 400
to 500 million cases of diarrhea each year worldwide (43). As
a food-borne pathogen, C. jejuni is widely distributed in food-
producing animals, including both livestock and poultry (18).
In animal reservoirs, C. jejuni colonizes the intestinal tracts of
animals and usually does not cause clinical diseases. But once
transmitted to a human host, it can cause severe gastroenteritis
(30). Transmission of Campylobacter bacteria from animals to
humans is mainly via contaminated poultry, water, and raw
milk (18). Among domestic animals, poultry is considered the
major reservoir for C. jejuni (61). The high prevalence of C.
jejuni on chicken farms suggests that this organism is well
adapted in the poultry production system, but the mechanisms
involved in the adaptation are poorly understood. Understand-
ing the adaptive mechanisms may facilitate the development of
intervention strategies to control the prevalence of this patho-
genic organism.
During the past decade, Campylobacter species have become
increasingly resistant to clinically important antibiotics such
as fluoroquinolones and macrolides (13, 35). Antimicrobials
including organoarsenical compounds, such as 3-nitro-4-hy-
droxyphenylarsonate (roxarsone), are commonly used in
poultry production in the United States and other countries
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(6). Roxarsone is given to broiler chickens as a feed additive to
promote growth and control coccidiosis, an intestinal disease
caused by Eimeria parasites (6). The roxarsone fed to chickens
is excreted into feces and subsequently converted to inorganic
arsenic (arsenite and arsenate) via the bioconversion processes
in poultry litter (8, 49). Since C. jejuni colonizes the intestinal
tracts of poultry, it is likely that Campylobacter bacteria are
often exposed to arsenic compounds and have adapted to the
selection pressure. Indeed, a recent study by Sapkota et al.
indicated that Campylobacter isolates from conventional poul-
try products were significantly more resistant to roxarsone than
those isolates from antimicrobial-free poultry products (44).
Despite these observations, the molecular mechanisms in-
volved in arsenic resistance in Campylobacter are unknown,
and the impact of the acquired arsenic resistance on the sus-
ceptibility of Campylobacter spp. to other antimicrobials, in-
cluding clinically important antibiotics, has not been deter-
mined.
Previously, Ahmed et al. compared the gene contents of C.
jejuni 81116 and NCTC 11168 using subtractive hybridization
and reported the presence of arsB and arsC in 81116 but not in
NCTC 11168 (2). Recently, the genomic sequences of several
C. jejuni strains were determined, which revealed the presence
of ars gene homologs located on Campylobacter chromosomes
(12, 17, 34, 36, 38). Comparison of the genomic sequences
of strains NCTC 11168, 81-176, and RM1221 revealed that
a four-gene operon (CJE1730, CJE1731, CJE1732, and
CJE1733) is present in RM1221, and three of the open reading
frames (ORFs) share significant sequence homology with
known ars genes, suggesting that this operon may be involved
in arsenic resistance in Campylobacter. In this study, we deter-
mined the contribution of this operon to arsenic resistance, its
induction by arsenic, and its regulation by the transcriptional
regulator ArsR. In addition, we examined if the ars operon
contributes to the resistance to nonarsenic antimicrobials in
Campylobacter. Findings from this study identify a new mech-
anism involved in arsenic resistance and sensing in Campy-
lobacter and provide new insights into the adaptation mecha-
nisms of Campylobacter bacteria in animal reservoirs.
MATERIALS AND METHODS
Plasmids, bacterial strains, and growth conditions. In total, 27 C. jejuni
isolates were used in this study. Of these strains, 10 (CT1-8, CT3-7, CT3-2,
CT2-2, CT1-20, CT1-17, CT4-3,CT4-12, CT4-23, and CT4-22) were isolated from
turkeys, 9 (CB2-1, CB2-2, CB3-6, CB4-4, CB8-16, CB7-22, CB6-27, CB5-28, and
RM1221) from chickens, and 7 (NCTC 11168, 81-176, F12469, 214274, Clev9100,
79034, and H52022) from humans. ATCC 33560 was from American Type
Culture Collection (Rockville, MD). These isolates were routinely grown in
Mueller-Hinton (MH) broth (Difco) or on MH agar at 42°C under microaero-
philic conditions (5% O2, 10% CO2, and 85% N2). Plasmids, various mutant
constructs, and cloning hosts used in this study are listed (see Table S1 in the
supplemental material).
Chemical compounds and antibiotics. The chemicals and antibiotics used in
this study included arsenite (NaAsO2), arsenate (Na2HAsO4), roxarsone, ampi-
cillin, erythromycin, streptomycin, tilmicosin, ciprofloxacin, kanamycin, oxytet-
racycline, ceftiofur, and polymyxin B. They were purchased from Sigma Chem-
ical Co. (St. Louis, MO).
Antimicrobial susceptibility tests. The MICs of various arsenic compounds
and antibiotics against C. jejuni strains were determined using the agar dilution
susceptibility testing method as described by CLSI (7) and the broth microdilu-
tion method as described previously (25). Each MIC test was repeated at least
three times.
PCR analysis. To determine the distribution of the arsenic resistance operon,
arsC-specific primers (arsCF and arsCR) and acr3-specific primers (cje1733F and
cje1733R) were designed from the genomic sequence of C. jejuni RM1221 (12)
and used in PCR analyses with the genomic templates of different C. jejuni
strains and Ex Taq polymerase (TaKaRa Bio Inc., Japan). PCR was performed
in a volume of 50 l containing 2 M of primers, 250 M of deoxynucleoside
triphosphates, and 5 U of Ex Taq polymerase. Annealing temperatures and
elongation times varied according to the primers used and the expected sizes of
products.
Sequence determination of the ars operon in C. jejuni strain CB5-28. To
facilitate the functional characterization of the ars operon, the ars genes in strain
CB5-28 were amplified by PCR and then the PCR products were subsequently
sequenced. The primers used in the PCR were designed from the published
genomic sequence of RM1221 (12). The entire ars operon and its flanking region
was first PCR amplified with primer pair Ars1_F and Ars3_R (see Table S2 in the
supplemental material) using the Pfu DNA polymerase, and the product was
subsequently sequenced using primers Ars1_F, Ars1_R, Ars2_F, Ars2_R,
Ars3_F, and Ars3_R (see Table S2 in the supplemental material).
Construction of the arsR, arsC, and acr3 mutants. In order to evaluate the
function of the operon in arsenic resistance, isogenic arsR, arsC, and acr3 mu-
tants were constructed. Initially, we tried to use C. jejuni RM1221, whose
genomic sequence was known (12), in order to construct the mutants, but
RM1221 was not transformable by natural transformation or electroporation
(data not shown), prohibiting the generation of the desired mutants. Thus, C.
jejuni CB5-28, which harbors an ars operon identical to that of RM1221 (Fig. 1),
was used for mutagenesis in this study. The plasmids and primers used in this
work are listed (see Tables S1 and S2 in the supplemental material). To construct
an isogenic arsC mutant of strain CB5-28, primers arsCF and arsCR were used
in PCR analysis (with the Pfu DNA polymerase) to amplify a 1.7-kb fragment
that spans from 800 bp upstream of the start codon of arsC to 500 bp downstream
of the stop codon of arsC. Within arsC, there is a unique EcoRV restriction site
in the middle of the ORF. The PCR product was cloned into the SmaI site of
pUC19, resulting in the construct pARSC, which was subsequently digested by
EcoRV. Primers kanNCOF and kanNCOR (see Table S2 in the supplemental
material) were used to amplify the 1.0-kb kanamycin resistance cassette (Kanr)
from plasmid pMW10 (54). The Kanr cassette was ligated to EcoRV-digested
pARSC, yielding the construct pARSCK, in which the Kanr cassette was inserted
into the arsC in the same direction of transcription. The pARSCK plasmid, as a
suicide vector, was electroporated into C. jejuni CB5-28. Transformants were
selected on MH agar containing 50 g/ml of kanamycin. Insertional mutagenesis
of the arsC gene in the C. jejuni transformants was confirmed by PCR. The arsC
mutant of CB5-28 was named LP001 in this study (see Table S1 in the supple-
mental material). To create the isogenic arsC mutant in strains CB3-6 and
F12469, the insertional mutation in arsC of CB5-28 was transferred into strains
CB3-6 and F12469 by natural transformation as described previously (53).
An isogenic acr3 mutant of strain CB5-28 was also constructed by insertional
mutagenesis. Primers cje1733F and cje1733R were used to amplify the entire
acr3 gene, which contains a unique EcoRI restriction site in the middle of the
ORF. The PCR product was cloned into pGEM-T (Promega, Madison, WI),
resulting in pCJE1733, which was further digested with EcoRI and treated with
the Klenow fragment (TaKaRa). The 1.0-kb chloramphenicol resistance cassette
(cat) was amplified with primers catF and catR (see Table S2 in the supplemental
material) from plasmid pUOA18 (52) and ligated to EcoRI-digested pCJE1733,
generating pCJE1733C, which was then electroporated into C. jejuni CB5-28.
Transformants were selected on MH agar plates containing 4 g/ml of chloram-
phenicol. The insertion of the cat gene into acr3 was confirmed by PCR using
primers cje1733F and cje1733R. The acr3 mutant of CB5-28 was named LP002
in this study (see Table S1 in the supplemental material).
To generate a nonpolar mutation in arsR, the in-frame deletion method de-
scribed by Hendrixson et al. (16) was used in this study. The pDRH173 and
pDRH265 plasmids that carry rpsL(Sm), which confers resistance to streptomy-
cin, and a cat::rpsL cassette, respectively (16), were used for the in-frame dele-
tion. pDRH173 was electroporated into CB5-28 to replace the endogenous rpsL
with rpsL(Sm) to generate a streptomycin-resistant CB5-28 strain. The arsR gene
was cloned into pGEM-T (Promega). The cat::rpsL cassette was prepared by
digesting pDRH265 with SmaI and subsequent purification with agarose gel
extraction (QIAquick gel extraction kit; Qiagen, Valencia, CA). The cassette was
then cloned into the XbaI site of arsR in pGEM-T to yield the pArsRC plasmid.
pArsRC was electroporated into the streptomycin-resistant CB5-28 strain, and
transformants were selected on MH agar containing chloramphenicol (10 g/
ml). The transformants were then transferred to MH agar plates containing
streptomycin to screen for streptomycin-susceptible transformants. A strain re-
sistant to chloramphenicol, but sensitive to streptomycin, was obtained and
VOL. 75, 2009 MECHANISMS OF ARSENIC RESISTANCE IN CAMPYLOBACTER 5065
 o
n
 Septem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://aem
.asm
.org/
D
ow
nloaded from
 
named LP003. The sensitivity of LP003 to streptomycin was due to the recessive
nature of rpsL(Sm) in the presence of a wild-type rpsL gene. To generate a
deletion in arsR, a 576-bp fragment upstream of arsR and an 804-bp fragment
downstream of arsR were PCR amplified with primer pairs DelF1/DelR1 and
DelF2/DelR2, respectively. The DelR1 and DelF2 primers were designed to
contain a 21-nucleotide overlapping sequence to be used as an annealing region
in the subsequent PCR ligation (see Table S2 in the supplemental material). The
PCR ligation linked the two fragments into one product, in which an in-frame
deletion (from nucleotide 4 to 297) within arsR was generated. The product of
PCR ligation was cloned into pGEM-T, and the plasmid construct was electro-
porated into the LP003 strain. Transformants were initially selected on MH
agar containing streptomycin (2 mg/ml) and then screened for chloramphen-
icol sensitivity by being grown on MH agar containing chloramphenicol (10
g/ml). In-frame deletion of arsR was confirmed by PCR and sequencing. The
arsR in-frame deletion mutant of CB5-28 was named LP004 (see Table S1 in
the supplemental material).
RT-PCR and real-time qRT-PCR. To determine if the ars operon is inducible
by arsenic, C. jejuni CB5-28 was cultured in MH broth with or without added
arsenite and arsenate for 16 h. The final concentrations of arsenite and arsenate
in the culture were 0.25 times their corresponding MIC in CB5-28. Total RNA
was extracted from four replicate cultures from each experiment and the culture
experiment repeated three times. To determine if the deletion of arsR affected
the expression of arsP, arsC, and acr3, wild-type CB5-28 and LP004 (arsR) were
grown in MH broth under identical conditions overnight to the late log phase.
Total RNA was extracted from four replicate cultures in each experiment, which
was repeated three times. RNA was extracted using the RNeasy mini kit (Qia-
gen) according to the procedure supplied with the product. The RNA prepara-
tions were further treated with the Turbo DNA-free kit (Ambion) to eliminate
DNA contamination in each preparation. The lack of DNA in each RNA sample
was confirmed by PCR. For real-time quantitative reverse transcription-PCR
(qRT-PCR), primer pairs 1730F1/1730R1, 1732F1/1732R1, and 1733F1/1733R1
(see Table S2 in the supplemental material) specific for arsP, arsC, and acr3,
respectively, were designed using the Primer3 online interface (http://frodo.wi
.mit.edu/). Each amplicon was analyzed by the Mfold server (http://mfold.bioinfo
.rpi.edu/) to avoid secondary RNA structures and hairpin loops. Real-time RT-
PCR analyses were conducted using the iScript one-step RT-PCR kit with SYBR
green (Bio-Rad) along with the MyiQ iCycler real-time PCR detection system
(Bio-Rad, Hercules, CA) as described in a previous publication (24). The 16S
rRNA gene was used for the normalization. To confirm whether inactivation of
arsC has a polar effect on downstream gene acr3, RT-PCR was performed with
Superscript II reverse transcriptase (Gibco BRL) according to the manufactur-
er’s instructions.
Cloning, expression, and purification of rArsR. Primers ArsRF1 (containing a
BamHI site) and ArsRF2 (containing an XmaI site) were used to amplify the
full-length arsR from CB5-28. The product was cloned into BamHI- and XmaI-
digested pQE30 expression vector (Qiagen). The construct was transformed into
Escherichia coli JM109. The plasmid in the E. coli clone expressing recombinant
His6-ArsR (rArsR) was sequenced, which confirmed the correct fusion of ArsR
to the His6 tag and the lack of mutations in the cloned arsR. Induction and
purification of the His-tagged rArsR under native conditions were performed
according to the instructions provided with the pQE30 expression vector. Once
eluted from the Ni2-nitrilotriacetic acid column, the rArsR was immediately
passed through a PD-10 desalting column (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) and stored at 80°C in single-use aliquots. The concentration
of the purified rArsR was determined using the bicinchoninic acid protein assay
kit (Pierce, Rockford, IL), with bovine serum albumin as a standard.
EMSA. To determine the binding of ArsR to the promoter region of the
arsenic resistance operon, an electrophoretic mobility shift assay (EMSA) was
performed using the method described in a previous publication (19). The
164-bp promoter region of the ars operon was amplified using primers gelF and
gelR (see Table S2 in the supplemental material) from C. jejuni CB5-28. The
DNA fragment was then labeled at the 3 end with digoxigenin (DIG)-11-ddUTP
using the DIG oligonucleotide 3-end-labeling kit (Roche Molecular Biochemi-
cals, Basel, Switzerland). A 190-bp intragenic DNA fragment of arsP was am-
plified with primers NCF and NCR (see Table S2 in the supplemental material),
labeled with DIG-11-ddUTP, and used as a negative control DNA for the
EMSA. For the competition experiments, a 50-bp DNA fragment containing the
inverted repeat sequence in the ars promoter was generated by annealing com-
plementary oligonucleotides CompF and CompR (see Table S2 in the supple-
mental material). The two oligonucleotides were dissolved in STE buffer (10 mM
Tris, pH 8.0, 50 mM NaCl, 1 mM EDTA) and were mixed in an equal molar
ratio. The mixture was heated to 94°C and slowly cooled. This double-stranded
DNA was used as competitor in the EMSA. Also, the competition assay was
carried out with the negative-control DNA amplified by primer NCF and NCR
(described above). To determine if arsenite and arsenate inhibited the binding of
ArsR to the promoter DNA, various amounts of arsenic (0.01, 0.1, and 1 mM for
arsenite; and 1, 8, and 32 mM for arsenate) were added to the binding reaction
mixtures.
Primer extension analysis. To identify the transcriptional start site of the ars
operon, oligonucleotide PEA-R (see Table S2 in the supplemental material),
FIG. 1. Genomic organization of the ars operon and confirmation of the generated ars mutants. (A) Diagram of the ars genes in C. jejuni strains
RM1221, CB5-28, NCTC 11168, and 81-176. ORFs are indicated by boxed arrows. The single promoter in front of arsP is depicted by a curved
arrow. In strains NCTC 11168 and 81-176, arsC and acr3 are absent and arsP and arsR are degenerate due to frameshift mutations (indicated by
black strips in the genes). An additional arsR homologue in NCTC 11168 and 81-176 (named arsR2) is indicated with a black arrow. (B) PCR
confirmation of the arsC::Kanr insertion in LP001. Lane 1, 1-kb DNA ladder; lane 2, LP001; and lane 3, wild-type CB5-28. (C) PCR confirmation
of the acr3::cat insertion in LP002. Lane 1, 1-kb DNA ladder; lane 2, wild-type CB5-28; and lane 3, LP002. (D) PCR confirmation of the in-frame
deletion in arsR in LP004. Lane 1, 100-bp DNA ladder; lane 2, wild-type CB5-28; and lane 3, LP004.
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complementary to the region immediately downstream of the start codon of the
arsP gene, was synthesized and 5-end labeled with 5-6-carboxyfluorescein by
IDT (Coralville, IA). Total RNA was isolated from a log-phase culture of the
arsR mutant (LP004) of CB5-28. Use of the mutant strain for primer extension
was based on the expectation that the mutant strain would produce more mRNA
transcripts of the ars operon than the wild-type strain due to the deletion of arsR,
thus yielding a better signal in the assay. The procedures for the primer extension
reaction and subsequent detection of the cDNA product were described in
previous publications (15, 19).
Statistical analysis. The MIC data for arsenite, arsenate, and roxarsone in
various C. jejuni strains were analyzed according to the PCR result of the ars
operon. Statistical comparison of the MICs of the strains with the ars operon and
those without the operon was performed by using the two-sample Wilcoxon-
Mann-Whitney test using the SAS software. A P value of 0.05 is considered
significant.
Nucleotide sequence accession number. The sequences for the ars genes have
been deposited in GenBank under accession no. EU916833.
RESULTS
Identification of the ars operon in Campylobacter. As the first
step to identify the genetic basis responsible for arsenic resis-
tance in C. jejuni, we compared the MICs of arsenic com-
pounds in three sequenced strains, including NCTC 11168
(34), 81-176 (17), and RM1221 (12). As shown in Table 1, the
MICs of roxarsone, arsenite, and arsenate in strains NCTC
11168 and 81-176 were 8, 4 to 8, and 128 g/ml, respectively,
while their MICs in RM1221 were 128, 64, and 2,048 g/ml,
respectively. This finding indicated that strain RM1221 had a
significantly higher level of resistance to arsenic compounds
than the other two strains. Comparison of the genomic se-
quences of RM1221, NCTC 11168, and 81-176 revealed a locus
potentially involved in the elevated resistance to arsenic com-
pounds (Fig. 1A). In RM1221, there is a four-gene cluster
including CJE1730, CJE1731, CJE1732, and CJE1733. Within
the locus, CJE1730 (315 amino acids [aa]) encodes a putative
membrane permease of an unknown function. We designate
CJE1730 and its orthologs in other C. jejuni strains as arsP
(arsenic resistance permease) in this study. CJE1731 (105 aa)
is separated from CJE1730 by 10 bp and was annotated as arsR
due to its high sequence homology with the transcriptional
regulators of the ArsR family (12). The third gene CJE1732
(423 aa) encodes a putative cytoplasmic arsenate reductase
and was annotated as arsC (12). The start codon of arsC over-
laps with the stop codon of arsR. CJE1733 (347 aa) overlaps
with arsC by six nucleotides, encodes a putative arsenic resis-
tance membrane transporter of the Acr3 family (12), and is
designated as acr3 in this study (Fig. 1A). The acr3 gene shares
little sequence homology with known arsB genes. Based on
their sequence homologies with genes encoding proteins of
known functions and the fact that the four genes are clustered
together on the chromosome (Fig. 1A), we designated this
four-gene locus as the ars operon in C. jejuni. RT-PCR using
primers spanning the junctions of the adjacent genes in the
operon confirmed cotranscription of the ars genes (data not
shown). Compared with RM1221, NCTC 11168 and 81-176 do
not have arsC and acr3 in the ars locus (Fig. 1A). The arsR gene
in NCTC 11168 and 81-176 is degenerated and split into two
small ORFs due to a frameshift mutation caused by a single-
nucleotide deletion in the coding sequence of arsR. In addition,
the arsP gene in strains NCTC 11168 and 81-176 is also de-
generated as result of a single-nucleotide deletion in the ORF.
Thus, strains NCTC 11168 and 81-176 lack an intact ars
operon. Interestingly, there is an additional transcriptional reg-
ulator upstream of arsP in NCTC 11168 and 81-176 (Fig. 1A)
and we named this putative regulator arsR2 based on the fact
that its sequence contains an ArsR domain. arsR2 appears to
be transcribed independently from arsP and is absent in
RM1221. The ars genes in strain CB5-28, which is also highly
resistant to arsenic (Table 1), were also sequenced in this study
(GenBank accession no. EU916833), which revealed that the
organization of the ars operon in CB5-28 was identical to that
of RM1221 (Fig. 1A). There was only one amino acid substi-
tution in ArsP encoded by the entire ars operon of CB5-28
compared with the ArsP sequence of RM1221. The immediate
flanking gene loci of the ars locus are conserved among differ-
ent C. jejuni strains and transcribed divergently from the ars
locus (Fig. 1A), with a hypothetical ORF located upstream and
a merR homolog located downstream. The differences in the
ars locus and the level of resistance to arsenic compounds
(Table 1) among RM1221, CB5-28, NCTC 11168, and 81-176
suggested that the ars operon contributed to arsenic resistance
in C. jejuni. This possibility was further examined by the fol-
lowing experiments.
The presence of arsC and acr3 is correlated with increased
resistance to arsenic compounds in different C. jejuni strains.
As the first step to examine if the four-gene (arsP, arsR, arsC,
and acr3) ars operon was associated with enhanced resistance
to arsenic compounds, PCR was performed using arsC- and
acr3-specific primers to determine the presence of arsC and
TABLE 1. MICs (g/ml) of arsenic compounds against different
C. jejuni strains and the presence of arsC and acr3 in the
strains as determined by PCRa
Strain
MIC (g/ml) Presence of
arsC and
acr3Rox As(III) As(V)
RM1221 128 64 2,048 
CT1-8 128 64 2,048 
CT3-7 16 64 128 
CT2-2 128 16 512 
CT1-20 32 64 128 
CT4-3 128 64 256 
CT4-12 64 8 512 
CT4-23 64 8 512 
CB8-16 64 32 1,024 
CB7-22 16 32 512 
CB6-27 16 32 1,024 
CB5-28 64 64 1,024 
CB3-6 16 64 512 
79034 128 16 1,024 
F12469 128 64 2,048 
214274 32 32 512 
H52022 256 8 256 
NCTC 11168 8 4 128 
81-176 8 8 128 
ATCC 33560 8 8 64 
CT3-2 64 16 32 
CT1-17 64 16 128 
CT4-22 32 16 128 
CB2-1 16 8 64 
CB2-2 32 8 64 
CB4-4 256 16 32 
Clev9100 128 8 256 
a PCR analysis was performed using arsC- and acr3-specific primers. Rox,
roxarsone; , positive PCR for both arsC and acr3; , negative PCR for both
arsC and acr3.
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acr3 in various C. jejuni isolates derived from different sources.
At the same time, the MICs of the arsenic compounds in these
isolates were also measured using the agar dilution method. As
shown in Table 1, arsC and acr3 were present in 17 of the 27
isolates examined in this study. In every strain examined, the
presence or absence of arsC and acr3 was concurrent, suggest-
ing that the two genes have coevolved. The PCR results indi-
cated that the ars operon was widely distributed in C. jejuni
isolates. Statistical analysis indicated that the presence of the
ars operon is significantly associated with elevated resistance to
arsenite (P  0.001) and arsenate (P  0.01), suggesting that
the ars operon encodes arsenic resistance mechanisms. Inter-
estingly, the MICs of roxarsone are not significantly different
between the strains with and without the ars operon (P 0.05),
implying that the ars operon does not contribute significantly
to roxarsone resistance in C. jejuni when assayed using the in
vitro MIC test.
Contribution of the ars operon to arsenic resistance in C.
jejuni. To define the role of the ars operon in arsenic resistance
in Campylobacter, arsR, arsC, and acr3 were disrupted by in-
sertional mutagenesis (for arsC and acr3) or in-frame deletion
(for arsR). Each mutant construct was confirmed by PCR (Fig.
1B to D), and the in-frame deletion in the arsR mutant was also
confirmed by sequence analysis. The mutants were compared
with the parent strain CB5-28 for susceptibility to arsenic com-
pounds using two methods, agar dilution and broth microdilu-
tion.
According to MIC results from the agar dilution method,
inactivation of arsC resulted in 4-fold and 32-fold reductions in
the MICs of arsenite and arsenate, respectively, while mutation
of acr3 led to eightfold and fourfold reductions in the MICs of
arsenite and arsenate, respectively (Table 2). In contrast to the
MIC changes associated with the mutation of arsC and acr3,
deletion of arsR resulted in an eightfold increase in the MIC of
arsenite but had no effect on the MIC of arsenate (Table 2).
All three mutants showed no changes in the MIC of roxarsone,
indicating that they are not directly associated with resistance
to this organic arsenic compound under the in vitro culture
conditions. The results from the agar dilution method were
also confirmed by the broth dilution method (Table 2). Al-
though the broth dilution method yielded higher MICs than
the agar dilution method with each compound, the differences
between the mutant strains and the wild-type strain were iden-
tical or similar to the results obtained with the agar dilution
method (Table 2). With both testing methods, inactivation of
arsC had a greater effect on the MIC of arsenate than on
arsenite, while mutation of acr3 had a higher impact on the
MIC of arsenite (Table 2). This is consistent with the predicted
functions of ArsC as an arsenate reductase and Acr3 as an
efflux transporter for arsenite. It should be pointed out that the
insertional mutation in arsC caused a polar effect on acr3,
because RT-PCR showed that the transcript of acr3 was greatly
reduced (approximately 10-fold) in the arsC mutant compared
with that in the wild-type strain (data not shown). This polar
effect might explain why inactivation of arsC also caused a
reduction of the MIC of arsenite. Neither the arsC mutation
nor the acr3 mutation affected the mRNA levels of arsP and
arsR as determined by real-time RT-PCR (data not shown).
Together, these results clearly indicate that arsC and acr3 con-
fer arsenic resistance in C. jejuni and deletion of arsR increased
the resistance to arsenite. Furthermore, we transferred the
arsC mutation to two additional clinical isolates (CB3-6 and
F12469) by natural transformation. In each strain, the muta-
tion led to 8-fold and 16-fold reductions in the MICs of arsen-
ite and arsenate, respectively (Table 3), confirming the finding
obtained with CB5-28. Together, these results strongly indicate
that the ars operon is important for arsenic resistance in C.
jejuni.
Mutation of the ars genes did not affect the susceptibility to
antibiotics. To examine if the ars operon is associated with
antibiotic resistance, we tested the susceptibilities of the wild-
type strain CB5-28 and its arsC, arsR, and acr3 mutants to
antibiotics of different classes, including erythromycin, tilmico-
sin, ciprofloxacin, enrofloxacin, oxytetracycline, ceftiofur, and
polymyxin B. No differences were observed between the wild
type and mutants in the susceptibilities to these compounds
(data not shown), indicating that the ars operon does not
confer resistance to antibiotics.
ArsR functions as a repressor for the ars operon. The se-
quence features of ArsR (see Fig. S1 in the supplemental
material) and the elevated MIC of arsenite in the arsR mutant
(Table 2) suggested that ArsR functions as a repressor for the
TABLE 2. MICs of different arsenic compounds against CB5-28 and its isogenic mutants determined by the agar dilution method and the
broth microdilution methoda
Arsenic compound
MIC (g/ml) determined by:
Agar dilution Broth microdilution
CB5-28 LP001 LP002 LP004 CB5-28 LP001 LP002 LP004
Roxarsone 64 64 64 64 256 256 256 256
Arsenite 64 16 (4) 8 (8) 512 (8) 128 32 (4) 8 (16) 1,024 (8)
Arsenate 1,024 32 (32) 256 (4) 1,024 4,096 128 (32) 512 (8) 4,096
a Numbers in parentheses indicate the fold change compared to CB5-28, which is the wild-type strain. LP001, LP002, and LP004 are the arsC, acr3, and arsR mutants,
respectively (see Table S1 in the supplemental material for details).
TABLE 3. MICs of arsenic in C. jejuni strains CB3-6 and F12469
and their arsC mutants as determined by agar dilution
Arsenic
MIC (g/ml)a
CB3-6 CB3-6 (arsC::Kanr) F12469 F12469 (arsC::Kanr)
Roxarson 32 32 128 128
Arsenite 64 8 (8) 64 8 (8)
Arsenate 1,024 64 (16) 2,048 128 (16)
a Numbers in parentheses indicate the fold change compared to the corre-
sponding wild-type strain.
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ars operon. To test this hypothesis, we determined the expres-
sion of the ars genes in the arsR mutant. Deletion of arsR did
not produce a polar effect on the downstream genes, as con-
firmed by RT-PCR (data not shown). In fact, qRT-PCR
showed that deletion of arsR increased expression of the other
three genes in the ars operon. Compared with the wild-type
strain, arsP, arsC, and acr3 in the arsR deletion mutant showed
64-, 75-, and 30-fold increases in transcription, respectively
(Fig. 2A). This result further indicates that ArsR functions as
a repressor inhibiting the expression of the ars operon in
Campylobacter.
The ars operon is inducible by arsenite and arsenate. To
determine if the expression of the ars operon is inducible by
arsenic compounds, strain CB5-28 was cultured in MH broth
with arsenite and arsenate. The transcription levels of arsP,
arsC, and acr3 in these cultures were compared with those
grown in MH broth without inducers using qRT-PCR. As
shown in Fig. 2B, the expression of arsP, arsC, and acr3 was
induced 39-, 31-, and 14-fold, respectively, by arsenite, and 38-,
20-, and 13-fold, respectively, by arsenate. This result clearly
indicated that the ars operon in Campylobacter is strongly in-
duced by arsenic compounds, which suggests that this system is
subject to transcriptional regulation. Interestingly, the induc-
tion of the ars genes was not at the same level, with arsP (close
to the ars promoter) showing the highest and acr3 (distant
from the ars promoter) the lowest fold changes in expression
(Fig. 2B). This difference is probably due to the polar expres-
sion effect, as observed with the ars operons in other bacteria
(22, 29).
Identification of the promoter for the ars operon. To under-
stand the regulatory mechanism of the ars operon, we first
identified its transcription start using primer extension. The
electropherogram showed a single distinct peak corresponding
to a cDNA fragment of 214 bases, which mapped the transcrip-
tion start to 20 nucleotides upstream of the start codon of arsP
(Fig. 3A and C). Based on the result of primer extension and
the reported consensus sequences of Campylobacter rpoD pro-
moters (37), the predicted 10 and 35 sequences were also
identified (Fig. 3A). Overlapping with the 35 site, there is an
18-bp inverted repeat forming a dyad structure, suggesting a
potential binding site for a regulatory protein. Interestingly,
similar inverted repeats are also present in the promoters of
the ars operons of Bacillus subtilis and Synechocystis species
(29, 45), and the core sequence [ATCAA(N)6TTGAT] is con-
served among the three organisms (Fig. 3B). In Synechocystis
species, the inverted repeat was mapped in the binding site of
ArsR (29).
ArsR binds specifically to the promoter of the ars operon.
The presence of an HTH motif in ArsR (see Fig. S1 in the
supplemental material) suggests that it is a DNA-binding pro-
tein. In addition, an 18-bp inverted repeat is present in the
promoter region of ars (Fig. 3A), suggesting a potential bind-
ing site for ArsR. To determine whether ArsR directly inter-
acts with the ars promoter, rArsR protein was expressed in
Escherichia coli. The rArsR was shown as a 13-kDa protein on
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(data not shown), comparable with the molecular mass (12.2
kDa) calculated from the deduced amino acid sequence of
ArsR. As shown with EMSA, rArsR formed complexes with
the 164-bp DNA fragment containing the promoter of the ars
operon in a dose-dependent manner (Fig. 3D) but did not bind
to the control DNA fragment amplified from the coding region
of arsP (data not shown). To further confirm the binding spec-
ificity of ArsR and determine if the inverted repeat in the ars
promoter region was involved in the binding, we performed
competition experiments using EMSA. A 50-bp DNA frag-
ment containing the inverted repeat was synthesized using
complementary oligonucleotides CompF and CompR (see Ta-
ble S2 in the supplemental material). In the competition reac-
tion, this unlabeled DNA fragment inhibited the binding of
ArsR to the ars promoter DNA (Fig. 3E). On the contrary, the
control DNA (coding region of arsP) did not block the binding
of ArsR to the promoter even at a 200-fold molar excess of the
promoter DNA (Fig. 3F). ArsR also did not show binding to an
unrelated promoter of cmeABC (data not shown) controlled by
CmeR, a TetR family transcription regulator (23). Together,
these results indicate that ArsR binds directly to the promoter
of the ars operon, specifically to the region containing the
inverted repeat.
Binding of ArsR to the ars promoter is inhibited by arsenite.
Since arsenic compounds induce the expression of the ars
operon (Fig. 2) and there is a conserved metal binding motif
(ELCVCDL) (48) in the ArsR (see Fig. S1 in the supplemental
FIG. 2. Expression levels of the ars genes as determined by qRT-
PCR. (A) Elevated expression of arsP, arsC, and acr3 in the arsR
deletion mutant (LP004) compared to the wild-type CB5-28. (B) In-
duction of arsP, arsC, and acr3 in CB5-28 by arsenite [As(III)] and
arsenate [As(V)] at a subinhibitory concentration. In both panels, each
bar represents the mean  standard deviation of three independent
experiments.
VOL. 75, 2009 MECHANISMS OF ARSENIC RESISTANCE IN CAMPYLOBACTER 5069
 o
n
 Septem
ber 29, 2017 by IO
W
A STATE UNIVERSITY
http://aem
.asm
.org/
D
ow
nloaded from
 
material), we suspected that arsenic compounds induce ars
expression by inhibiting the interaction of ArsR with the target
promoter. To test this hypothesis, we investigated the effect of
arsenite and arsenate on the binding of ArsR to the pro-
moter DNA in EMSA. The results demonstrated that arsen-
ite inhibited the formation of the ArsR-DNA complex in a
dose-dependent manner and completely released ArsR from
the DNA at a concentration of 1 mM (Fig. 4). On the other
hand, arsenate did not inhibit the binding of ArsR to the
promoter DNA even at a concentration of 32 mM. These
FIG. 3. Regulation of the ars operon. (A) Sequence features of the ars promoter. The start codon (ATG) of arsP is bold. The transcript start (base
T) is marked as1, and a curved arrow indicates the direction of transcription. The predicated ribosomal binding site (RBS) is underlined. The putative
10,16, and35 boxes are underlined. The inverted repeat is overlined with inverted arrows. (B) Alignment of the ArsR binding sites among C. jejuni,
B. subtilis, and Synechocystis. The conserved sequences are bold and underlined. (C) An electropherogram showing the result of primer extension analysis
of the ars promoter. The extension product is indicated by an arrowhead. The 5-6-carboxyfluorescein-labeled size standards are marked with asterisks.
(D) Binding of ArsR to the ars promoter as determined by EMSA. A 164-bp DIG-labeled DNA fragment containing the ars promoter was incubated
with 0 ng (lane 1), 5 ng (lane 2), 10 ng (lane 3), and 20 ng (lane 4) of rArsR. (E) Competition assay to confirm the binding specificity of ArsR. Each binding
reaction was conducted with the DIG-labeled promoter DNA and 20 ng of ArsR in the presence of the competing DNA (a 50-bp probe containing the
IR). The competing DNA was added at a zerofold (lane 2), 50-fold (lane 3), 100-fold (lane 4), and 200-fold (lane 5) molar excess of the DIG-labeled
promoter DNA. Lane 1 contains the DIG-labeled promoter DNA only (no rArsR). (F) Competition assay using a DNA fragment amplified from the
coding sequence of arsP, which was added with no (lane 2), 50-fold (lane 3), 100-fold (lane 4), and 200-fold (lane 5) excess of the DIG-labeled promoter
DNA. Lane 1 contains the DIG-labeled promoter DNA only.
FIG. 4. Effect of arsenite (A) and arsenate (B) on the formation of ArsR-DNA complexes as determined by EMSA. The concentrations of
arsenic used in the reaction are indicated at top of each panel. Each reaction was performed with 5 ng of DIG-labeled ars promoter DNA. , 20
ng of rArsR was added in the reaction; , rArsR was absent in the reaction.
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results suggest that arsenite directly inhibits the interaction
of ArsR with the target DNA, while arsenate is inefficient in
the inhibition.
DISCUSSION
In this study, a four-gene ars operon was identified that
contributes to arsenic resistance in C. jejuni. Genes in this
operon encode two putative membrane transporters (ArsP and
Acr3), a transcriptional regulator (ArsR), and an arsenate re-
ductase (ArsC). Compared to the ars operons in other bacte-
ria, the C. jejuni ars is atypical in terms of gene contents
because it encodes two membrane transporters that show little
sequence homology with the ArsB described in E. coli and
other bacteria. There are two unrelated families of arsenite
transporters in bacteria: the ArsB family and the Acr3 family
(40, 41). The ArsB family has so far been identified only in
bacteria, while the Acr3 family is present in bacteria, fungi, and
archaea. ArsB has 12 membrane-spanning segments and ex-
trudes both arsenite and antimonite (40). In contrast, Acr3 has
10 predicted transmembrane helices and is an arsenite-specific
transporter in bacteria. Limited sequence homology exists be-
tween ArsB and Acr3. ArsB either functions alone using mem-
brane potential in the efflux of arsenite or partners with ArsA
(ATPase) to form a highly efficient ATP-driven arsenite efflux
pump. Acr3 utilizes membrane potential for the efflux of ar-
senite. The majority of bacterial ars operons possess arsB in-
stead of acr3 (41), which has been reported only in a few
bacteria (29, 45, 51). However, a recent survey of soil bacteria
using acr3-specific PCR analysis indicated that the acr3 gene is
widely distributed in different bacterial species (1). Results
from this study indicate that the acr3 gene is frequently present
in various C. jejuni strains isolated from different sources (Ta-
ble 1). In addition, an acr3 homolog is also present in two
recently sequenced C. jejuni strains, including 81116 and a
clinical isolate from Thailand (36, 38). Together, these findings
suggest that the acr3 class of arsenic transporters is more
commonly present in bacteria than previously expected.
In the ars operon described in this study (Fig. 1A), the first
ORF (arsP) encodes a putative permease of the major facili-
tator family. Predicted with TMHMM 2.0, ArsP has eight pre-
dicted transmembrane helices and a large hydrophilic loop (67
amino acids) in the central portion (between helices four and
five) of the protein. The central hydrophilic loop is predicted to
be outside the membrane. ArsP has little sequence homology
with proteins encoded by either arsB or acr3. Since arsP is in
the ars operon and is controlled by ArsR (Fig. 2), it is possible
that ArsP also contributes to arsenic resistance in Campy-
lobacter. However, attempts to inactivate the arsP gene by
in-frame deletion were not successful for unknown reasons.
Thus, how ArsP contributes to arsenic resistance in Campy-
lobacter remains to be determined in future studies.
Analysis of multiple clinical isolates revealed a statistically
significant association between harboring this ars operon and
elevated resistance to arsenite and arsenate (Table 1). Further-
more, inactivation of arsC and acr3 in Campylobacter de-
creased its resistance to arsenite and arsenate (Tables 2 and 3).
These findings indicate that this ars operon is an important
player in conferring arsenic resistance in Campylobacter. Sur-
prisingly, several strains (CT3-7, CT1-20, CT4-3, and H52022)
appeared to harbor this operon based on the PCR result but
did not show substantially elevated resistance to arsenic com-
pared to those strains that lacked the operon (Table 1). A
possible explanation for this discrepancy is that the ars operon
in these strains is not functional due to sequence degeneration.
This possibility remains to be verified by sequencing the ars
operon in the strains, which will determine if frameshift mu-
tations or other changes in the ars genes have occurred in the
strains. Interestingly, inactivation of arsC and acr3 did not
affect the susceptibility to roxarsone (an organic arsenic com-
pound), suggesting that this operon is not directly involved in
the detoxification of roxarsone. However, roxarsone is eventu-
ally converted to inorganic arsenic in poultry litter (8, 49).
Thus, this ars system would play an indirect role in the resis-
tance to roxarsone. In addition to the ars operon, C. jejuni also
has other putative arsenic resistance genes. For example, the
updated annotation of strain NCTC 11168 (http://www.lshtm
.ac.uk/pmbu/crf/Cj_updated.art) indicates that this strain has
three additional ars genes, including CJ0258 (an arsR ho-
molog), CJ0717 (an arsC homolog), and CJ1187c (an arsB
homolog). These individual genes are located far apart on the
chromosome and have not been functionally characterized.
Whether they contribute to arsenic resistance in Campy-
lobacter awaits further investigation.
It was shown in this study that ArsR encoded by the second
gene in the operon serves as a repressor for the ars system in
C. jejuni. This conclusion is based on the fact that deletion of
arsR greatly increased the expression of the ars genes (Fig. 2A)
and the resistance to arsenite (Table 2). Interestingly, the arsR
deletion mutant (LP004) did not affect the MIC of arsenate
(Table 2), suggesting that the elevated expression of the ars
operon in LP004 did not make a difference in the resistance to
arsenate. This observation may be explained by the possibility
that the inducible expression of the ars operon in the presence
of arsenate is as effective as the arsR deletion in conferring the
resistance to arsenate. Alternatively, multiple mechanisms are
involved in the detoxification of arsenate in Campylobacter and
overexpression of the ars system alone does not necessarily
show an obvious change in the resistance to arsenate.
As a transcriptional repressor, ArsR binds specifically to the
promoter region of the ars operon (Fig. 3D). Since the inverted
repeat sequence inhibited the binding of ArsR to the promoter
DNA (Fig. 3E), the dyad symmetry in the promoter region is
likely to be the binding site of ArsR. The ArsR binding site
overlaps with the 35 site of the ars promoter (Fig. 3A). Thus,
binding by ArsR would presumably block the interaction of
RNA polymerases with the promoter and inhibit the initiation
of transcription. Interestingly, the inverted repeat sequence is
also partially present in the ars promoters of B. subtilis and
Synechocystis spp. (29, 45), and the core dyad sequence ATC
AA(N)6TTGAT was conserved among the three organisms
(Fig. 3B). In E. coli, TCAT(N)7TTTG was found to be the
consensus binding site for the ArsR of both plasmid and chro-
mosomal origins (58), which is also somewhat similar to the
conserved ArsR binding site identified in this study. These
observations suggest that ArsR proteins from bacterial species
have conserved certain binding specificity. As a member of the
metalloregulatory protein family, the ArsR in Campylobacter is
expected to bind to DNA as homodimers. As shown by EMSA
(Fig. 3D), up to three shifted bands were observed with the
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promoter DNA upon the addition of ArsR, which might rep-
resent different forms of the DNA-protein complexes. This
possibility remains to be examined in future studies. With the
SmtB metalloregulatory protein in cyanobacteria, it has been
known that up to four dimers can bind to a single inverted
repeat (11, 21, 28).
The expression of the ars operon in Campylobacter was in-
ducible by both arsenite and arsenate (Fig. 2B), but only ar-
senite inhibited the binding of ArsR to the operator DNA (Fig.
4), indicating that arsenite is the true inducer of ArsR. Similar
findings were observed with arsenic induction in E. coli (56).
The discrepancy between the in vivo induction and the in vitro
binding inhibition can be explained by the fact that arsenate is
converted to arsenite by ArsC in bacterial cells. It was possible
that the added arsenate in the Campylobacter cultures was
reduced to arsenite by ArsC, which then inhibited the function
of ArsR, leading to induction of the ars operon (Fig. 2B). In E.
coli, it has been shown that arsenite binds to the Cys residues
in the metal binding box of ArsR, and this interaction presum-
ably causes a conformational change in ArsR, leading to the
dissociation of ArsR from the promoter DNA (47). The ArsR
in C. jejuni also has the highly conserved metal binding motif
(see Fig. S1 in the supplemental material). Thus, it is conceiv-
able that induction of ArsR by arsenite in Campylobacter also
occurs at this site, which will be confirmed in future studies.
Notably, the rArsR is unstable during purification and storage.
To avoid this problem, we adopted a rapid purification proto-
col and froze the purified rArsR in single-use aliquots imme-
diately after purification. Each aliquot was used only once for
EMSA. The instability of the purified rArsR is probably due to
the formation of intra- and intermolecular disulfide bonds re-
sulting from the oxidation of the free thiol groups of the cys-
teine residues. This problem was observed with other purified
regulatory proteins, such as QacR and MerR (14, 46). The
Campylobacter ArsR has three Cys residues, two in the metal
binding box and one at the C terminus (see Fig. S1 in the
supplemental material). Their involvement in rapid formation
of disulfide bonds may be responsible for the loss of binding
activity of rArsR during storage.
As a major food-borne human pathogen, Campylobacter spp.
are commonly present in farm animals and their production
environment (18). Particularly, poultry harbors large numbers
of Campylobacter bacteria and are considered a natural habitat
for this organism (61). Since arsenic compounds are frequently
used for growth promotion and disease prevention in poultry
production (6), Campylobacter bacteria are likely exposed to
arsenic at a level that is higher than that in the natural envi-
ronment. Work presented in this study identifies a new arsenic-
sensing and resistance mechanism in C. jejuni, which may have
evolved to facilitate Campylobacter adaptation in the poultry
production system. Our findings provide new insights into the
adaptive mechanisms of Campylobacter bacteria in animal res-
ervoirs and open a new direction for us to understand how
antimicrobial usage in animal production affects the physiology
and ecology of food-borne pathogens.
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